Cargando…

Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel

In a large cohort of United States healthcare personnel without prior coronavirus disease 2019 (COVID-19) infection, 94 382 doses of messenger RNA (mRNA) COVID-19 vaccine were administered to 49 220 individuals. The adjusted vaccine effectiveness following 2 doses of each of the 2 available brands o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Swift, Melanie D, Breeher, Laura E, Tande, Aaron J, Tommaso, Christopher P, Hainy, Caitlin M, Chu, Haitao, Murad, M Hassan, Berbari, Elie F, Virk, Abinash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Online Only Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135611/ https://www.ncbi.nlm.nih.gov/pubmed/33900384 http://dx.doi.org/10.1093/cid/ciab361

Ejemplares similares

Impact of the Coronavirus Disease 2019 (COVID-19) Vaccine on Asymptomatic Infection Among Patients Undergoing Preprocedural COVID-19 Molecular Screening
por: Tande, Aaron J, et al.
Publicado: (2021)

Utility of Follow-up Coronavirus Disease 2019 (COVID-19) Antigen Tests After Acute Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Healthcare Personnel
por: Tande, Aaron J, et al.
Publicado: (2022)

Unrecognized severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence among healthcare personnel in a low-prevalence area
por: Shah, Vishal P., et al.
Publicado: (2020)

Hybrid Immunity Provides Protective Advantage Over Vaccination or Prior Remote Coronavirus Disease 2019 Alone
por: Virk, Abinash, et al.
Publicado: (2023)

Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients With Coronavirus Disease 2019
por: Magleby, Reed, et al.
Publicado: (2020)

Severe Acute Respiratory Syndrome Coronavirus 2 RNA in Serum as Predictor of Severe Outcome in Coronavirus Disease 2019: A Retrospective Cohort Study
por: Hagman, Karl, et al.
Publicado: (2020)

Repeated Coronavirus Disease 2019 Molecular Testing: Correlation of Severe Acute Respiratory Syndrome Coronavirus 2 Culture With Molecular Assays and Cycle Thresholds
por: Gniazdowski, Victoria, et al.
Publicado: (2020)

Population Mobility and Aging Accelerate the Transmission of Coronavirus Disease 2019 in the Deep South: A County-Level Longitudinal Analysis
por: Zeng, Chengbo, et al.
Publicado: (2022)

Improving the Outcomes of Immunocompromised Patients With Coronavirus Disease 2019
por: Haidar, Ghady, et al.
Publicado: (2021)

COVID-19 Infections in Health Care Personnel by Source of Exposure and Correlation With Community Incidence
por: Wight, Elizabeth, et al.
Publicado: (2022)

Compassionate Use of Remdesivir in Pregnant Women With Severe Coronavirus Disease 2019
por: Burwick, Richard M, et al.
Publicado: (2020)

Rapid Real-time Tracking of Nonpharmaceutical Interventions and Their Association With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positivity: The Coronavirus Disease 2019 (COVID-19) Pandemic Pulse Study
por: Clipman, Steven J, et al.
Publicado: (2020)

Bioaerosol Sampling for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a Referral Center with Critically Ill Coronavirus Disease 2019 (COVID-19) Patients March–May 2020
por: Lane, Morgan A, et al.
Publicado: (2021)

Invasive Fungal Disease Complicating Coronavirus Disease 2019: When It Rains, It Spores
por: Hoenigl, Martin
Publicado: (2020)

Systematic Testing for Influenza and Coronavirus Disease 2019 Among Patients With Respiratory Illness
por: Flannery, Brendan, et al.
Publicado: (2020)

Statewide Interventions and Coronavirus Disease 2019 Mortality in the United States: An Observational Study
por: Yehya, Nadir, et al.
Publicado: (2020)

Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case Study
por: Hensley, Matthew K, et al.
Publicado: (2021)

Insights on Coronavirus Disease 2019 Epidemiology From a Historic Cruise Ship Quarantine
por: Yamagishi, Takuya, et al.
Publicado: (2020)

Improving Surveillance Estimates of Coronavirus Disease 2019 (COVID-19) Incidence in the United States
por: Rosenberg, Eli S, et al.
Publicado: (2020)

A Framework for Sustainable Contact Tracing and Exposure Investigation for Large Health Systems
por: Breeher, Laura, et al.
Publicado: (2020)

Multiple SARS-CoV-2 Reinfections: A Case Series of Thrice-Infected Individuals
por: Swift, Melanie D., et al.
Publicado: (2022)

Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial
por: Rajasingham, Radha, et al.
Publicado: (2020)

Implications of Coronavirus Disease 2019 (COVID-19) Antibody Dynamics for Immunity and Convalescent Plasma Therapy
por: Casadevall, Arturo, et al.
Publicado: (2020)

Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Patients Who Received Compassionate-Use Leronlimab
por: Yang, Bryant, et al.
Publicado: (2020)

Differential Household Attack Rates Mirror the Ability to Control Coronavirus Disease 2019 (COVID-19)
por: Cook, Alex R, et al.
Publicado: (2020)

Racial Disparities in Coronavirus Disease 2019 (COVID-19) Mortality Are Driven by Unequal Infection Risks
por: Zelner, Jon, et al.
Publicado: (2020)

Absence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Activity in Prepandemic Sera From Individuals With Recent Seasonal Coronavirus Infection
por: Poston, Daniel, et al.
Publicado: (2020)

Coronavirus Disease 2019 (COVID-19) Disparities: A Call for Equity in Health Outcomes and Clinical Research
por: Linas, Benjamin P, et al.
Publicado: (2020)

Response to Correspondence: Baricitinib: Impact on Coronavirus Disease 2019 (COVID-19) Coagulopathy? Jorgensen et al
por: Titanji, Boghuma K, et al.
Publicado: (2020)

Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care
por: Olender, Susan A, et al.
Publicado: (2020)

Convalescent Plasma for Patients With Severe Coronavirus Disease 2019 (COVID-19): A Matched Cohort Study
por: Rogers, Ralph, et al.
Publicado: (2020)

Immunomodulation as Treatment for Severe Coronavirus Disease 2019: A Systematic Review of Current Modalities and Future Directions
por: Meyerowitz, Eric A, et al.
Publicado: (2020)

Persons With Human Immunodeficiency Virus and the Coronavirus Disease 2019 Pandemic: A Viral Synergy of Biology and Sociology
por: Collins, Lauren F
Publicado: (2020)

Coronavirus Disease 2019 (COVID-19), Organ Transplantation, and the Nuances of Immunomodulation: Lessons Learned and What Comes Next
por: Haidar, Ghady
Publicado: (2020)

Frequency of Routine Testing for Coronavirus Disease 2019 (COVID-19) in High-risk Healthcare Environments to Reduce Outbreaks
por: Chin, Elizabeth T, et al.
Publicado: (2020)

Comprehensive Health Assessment 3 Months After Recovery From Acute Coronavirus Disease 2019 (COVID-19)
por: van den Borst, Bram, et al.
Publicado: (2020)

Infant Outcomes Following Maternal Infection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): First Report From the Pregnancy Coronavirus Outcomes Registry (PRIORITY) Study
por: Flaherman, Valerie J, et al.
Publicado: (2020)

Clinical Epidemiology of Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) in Japan: Report of the COVID-19 Registry Japan
por: Matsunaga, Nobuaki, et al.
Publicado: (2020)

Dose-response Relation Deduced for Coronaviruses From Coronavirus Disease 2019, Severe Acute Respiratory Syndrome, and Middle East Respiratory Syndrome: Meta-analysis Results and its Application for Infection Risk Assessment of Aerosol Transmission
por: Zhang, Xiaole, et al.
Publicado: (2020)

Why Contact Tracing Efforts Have Failed to Curb Coronavirus Disease 2019 (COVID-19) Transmission in Much of the United States
por: Clark, Eva, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o7k6rfj8pbeparq53dn8ellbjd